
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
NCS-1 CRISPR/Cas9 KO Plasmid (h) | sc-404303 | 20 µg | $397.00 |
NCS1 encodes neuronal calcium sensor-1 (NCS-1), a conserved EF-hand Ca²⁺-binding protein that translates intracellular calcium transients into signaling outputs at membranes and synapses. NCS-1 regulates processes including vesicle trafficking and exocytosis, neurite outgrowth, and modulation of receptor and ion channel function through interactions with targets such as phosphatidylinositol 4-kinases and signaling complexes that shape phosphoinositide-dependent pathways. In human cells, NCS-1 contributes to calcium-dependent control of neuronal excitability and synaptic plasticity, linking stimulus-evoked Ca²⁺ flux to downstream adaptive responses. Altered NCS-1 expression or signaling has been investigated in the context of neuropsychiatric and neurodegenerative phenotypes, supporting its relevance for mechanistic studies of calcium signaling dysregulation.
NCS-1 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the NCS1 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the NCS1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the NCS1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish NCS-1 protein expression.
This CRISPR knockout system enables efficient generation of NCS1-deficient cell models for investigation of NCS-1 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.